The NHS says tirzepatide (Mounjaro) and semaglutide (Wegovy) are weight-loss injections that help reduce appetite and slow stomach emptying, and that they should only be prescribed alongside programmes that support healthier eating and physical activity
Recommended November/December 2025 Practical Dermatology Nov/Dec 2025: Page-Turner Format November/December 2025 GLP-1 Receptor Agonists and the Aesthetic Patient: Considerations for the Dermatologist Ardalan Minokadeh, MD, PhDArdalan Minokadeh, MD, PhD November/December 2025 Effectiveness of Early Moisturizer Use in Atopic Dermatitis Prevention Yi Gao
Diabetes Management For individuals with type 2 diabetes, semaglutide works by enhancing the bodys ability to lower blood sugar levels
It comprises a polyphenolic composition that includes gallotannins, gallic acid, and quinic acid
Artificial intelligence integrated nano biosensor technology: A breakthrough in early detection and sustainable management of phytonematodes
Reviews on ghrelin / GHSR-1a receptor signaling and growth-hormone secretagogues (mechanism context)